KQED Radio Staff
Amy Standen is a science reporter for KQED whose work also appears on Morning Edition, All Things Considered, Marketplace and other shows. She was a 2013-14 Rosalynn Carter Fellow for Mental Health Reporting and lives in San Francisco with her family.Her email is firstname.lastname@example.org and you can follow her on Twitter at @amystanden.
Stories (251 archives)
In Silicon Valley, the world's largest Apple product is taking shape: a glass and concrete ring wider than the Pentagon. Apple is known for keeping tight control over its product development, and the new campus is no exception. Reporter Amy Standen got a rare tour and asked some neighbors what they think.
At Stanford's Center for Sleep Sciences and Medicine, there's an unusual group of patients who suffer from narcolepsy who are helping doctors and researchers. They're chihuahuas, poodles and other dogs with a genetic predisposition to the sleep disorder. KQED Science reporter Amy Standen joins us to explain.
A new UC Berkeley research facility is devoted to finding cures for genetic diseases like cancer and cystic fibrosis. The Innovative Genomics Initiative will have a $20 million annual budget, and will use a technology called CRISPR: a fast and precise way to make changes, or fixes, inside the DNA of a cell.
Schizophrenia causes millions of Americans to hallucinate, hearing voices that seem to come from nowhere. Since the 1950s, doctors have prescribed strong anti-psychotic drugs to quell those voices. But one local researcher suggests a controversial new theory, drawing from other cultures. The theory says that in some cases, those voices may be helpful.
Walk through the streets of almost any big city in California, and you're likely to encounter homeless people suffering from schizophrenia. The symptoms -- disturbing hallucinations and delusions -- are frightening and obvious. And yet we know almost nothing about the biology of schizophrenia. There's no blood test for it, and no scan that can diagnose it. In the second of a three-part series on schizophrenia, we meet scientists who are redefining the disease and proposing new treatments.